Showing results (541-550 of 3,353) with videos related to
Sort By:
Pageof 336
The Lancet. Oncology|March 2, 2012
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 studyJean-Yves Pierga, Thierry Petit, Thierry Delozier, et al.The Lancet. Oncology|December 17, 2015
Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison studySabine Vogler, Agnes Vitry, Zaheer-Ud-Din BabarThe Lancet. Oncology|December 18, 2015
Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trialPhilippe Robin, Pierre-Yves Le Roux, Benjamin Planquette, et al.The Lancet. Oncology|December 19, 2015
Classification of treatment-related mortality in children with cancer: a systematic assessmentSarah Alexander, Jason D Pole, Paul Gibson, et al.The Lancet. Oncology|February 25, 2016
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trialsJennifer S Temel, Amy P Abernethy, David C Currow, et al.The Lancet. Oncology|December 15, 2015
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based studyStephen W Duffy, Amanda Dibden, Dimitrios Michalopoulos, et al.The Lancet. Oncology|November 26, 2015
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient dataDidier Meulendijks, Linda M Henricks, Gabe S Sonke, et al.The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.The Lancet. Oncology|November 8, 2015
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomasClémentine Sarkozy, Alexandra Traverse-Glehen, Bertrand CoiffierThe Lancet. Oncology|November 8, 2015
Inflammatory breast cancer: unique biological and therapeutic considerationsWendy A WoodwardPageof 336